GWCM
ZBH icon

Godshalk Welsh Capital Management’s Zimmer Biomet ZBH Stock Holding History

Godshalk Welsh Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-824
Closed -$91K – 254
2014
Q4 		$91K Buy
+824
New +$86.9K 0.08% 171

Other funds holding ZBH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Godshalk Welsh Capital Management's ZBH Position: Q1 2015 in Review

Godshalk Welsh Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2015, closing a stake of 824 shares — an estimated $91K sold.

Godshalk Welsh Capital Management first reported a position in ZBH in Q4 2014 and held it in 1 quarter. The position peaked at $91K in Q4 2014. 762 funds tracked by Wall St. Rank hold ZBH as of Q1 2015.

  • Godshalk Welsh Capital Management reported no remaining Zimmer Biomet position as of Q1 2015 after selling out during the quarter.
  • Godshalk Welsh Capital Management sold 824 Zimmer Biomet shares in Q1 2015, an estimated $91K.
  • Godshalk Welsh Capital Management first reported a position in Zimmer Biomet in Q4 2014 and held it in 1 quarter.
  • Godshalk Welsh Capital Management's Zimmer Biomet position peaked at $91K in Q4 2014.
  • 762 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2015.

Based on Godshalk Welsh Capital Management's 13F filing for Q1 2015, filed 12 May 2015.